Literature DB >> 16631377

Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses.

Laura N Antar1, Chanxia Li, Honglai Zhang, Reed C Carroll, Gary J Bassell.   

Abstract

Genetic deficiency of the mRNA binding protein FMRP results in the most common inherited form of mental retardation, Fragile X syndrome. We investigated the localization and function of FMRP during development of hippocampal neurons in culture. FMRP was distributed within granules that extended into developing axons and growth cones, detectable at distances over 300 microm from the cell body. In mature cultures, FMRP granules were present in both axons and dendrites, with pockets of higher concentrations appearing intermittently, along distal axon segments and near synapses. MAP1b mRNA, a known FMRP target, was also localized to axon growth cones. Morphometric analysis of growth cones from the FMR1 KO revealed both excess filopodia and reduced motility. At later stages during synapse formation, FMR1 KO neurons exhibited excessive filopodia and long spines along dendrites, yet there was a marked decrease in the density of spine-like protrusions juxtaposed to presynaptic terminals. In contrast, there was no difference in the density of shaft synapses between FMR1 KO and WT. Brief depolarization of WT neurons resulted in increased numbers of filopodia and spine synapses, whereas no additional morphologic changes were observable in dendrites of FMR1 KO neurons that already had increased density of filopodia-spines. These findings suggest that alterations in the regulation of axonal growth and innervation in FMR1 KO neurons may contribute to the dendritic and spine pathology in Fragile X syndrome. This work has broader implications for understanding the role of mRNA binding proteins in developmental and protein-synthesis-dependent plasticity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631377     DOI: 10.1016/j.mcn.2006.02.001

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  137 in total

1.  Delayed stabilization of dendritic spines in fragile X mice.

Authors:  Alberto Cruz-Martín; Michelle Crespo; Carlos Portera-Cailliau
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  The trouble with spines in fragile X syndrome: density, maturity and plasticity.

Authors:  C X He; C Portera-Cailliau
Journal:  Neuroscience       Date:  2012-04-20       Impact factor: 3.590

3.  hnRNP Q regulates Cdc42-mediated neuronal morphogenesis.

Authors:  Hung-Hsi Chen; Hsin-I Yu; Wen-Cheng Chiang; Yu-De Lin; Ben-Chang Shia; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2012-04-09       Impact factor: 4.272

Review 4.  Understanding neuronal connectivity through the post-transcriptional toolkit.

Authors:  Carlos M Loya; David Van Vactor; Tudor A Fulga
Journal:  Genes Dev       Date:  2010-04-01       Impact factor: 11.361

Review 5.  Cytoplasmic RNA-binding proteins and the control of complex brain function.

Authors:  Jennifer C Darnell; Joel D Richter
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

Review 6.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

7.  Exploring the zebra finch Taeniopygia guttata as a novel animal model for the speech-language deficit of fragile X syndrome.

Authors:  Claudia Winograd; Stephanie Ceman
Journal:  Results Probl Cell Differ       Date:  2012

8.  Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A convergently regulate the synaptic ratio of ionotropic glutamate receptor subclasses.

Authors:  Luyuan Pan; Kendal S Broadie
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

9.  Nerve growth factor-induced formation of axonal filopodia and collateral branches involves the intra-axonal synthesis of regulators of the actin-nucleating Arp2/3 complex.

Authors:  Mirela Spillane; Andrea Ketschek; Chris J Donnelly; Almudena Pacheco; Jeffrey L Twiss; Gianluca Gallo
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

Review 10.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.